2 research outputs found

    Incidence and clinical outcomes of the different neovascular forms of age-related macular degeneration in Valencia (Spain)

    No full text
    Objetivo Analizar la incidencia y los resultados visuales de cada uno de los subtipos de lesi贸n neovascular en pacientes con degeneraci贸n macular asociada la edad (DMAE). Material y m茅todos Revisi贸n retrospectiva de pacientes con DMAE neovascular tratados en el Hospital Universitario y Polit茅cnico la Fe de Valencia por un mismo retin贸logo (RGP) desde diciembre de 2012 hasta julio del 2015. Se registraron las formas anat贸micas del complejo neovascular, as铆 como el n煤mero de tratamientos intrav铆treos administrados y el cambio de visi贸n obtenido con este. Resultados Fueron incluidos 174 ojos de 156 pacientes con una edad media de 79,9 a帽os y un seguimiento de al menos 4 meses. El 40,8% presentaban neovascularizaci贸n coroidea (NVC) tipo 1; el 12%, tipo 2; el 31%, tipo 3; el 14,4% presentaban formas mixtas y el 1,7%, vasculopat铆a polipoidea. La agudeza visual inicial media era de 0,32 y de 0,38 a los 24 meses, habiendo recibido una media de 9,3 inyecciones. Las formas neovasculares tipo 2, 3 y mixtas mostraron un resultado visual significativamente inferior a las tipo 1, no existiendo significaci贸n estad铆stica en la vasculopat铆a polipoidea. Conclusiones La NVC tipo 1 fue la m谩s observada, y adem谩s se relacion贸 con un mejor pron贸stico visual, en comparaci贸n con el resto de lesiones neovasculares, en pacientes tratados con ranibizumab.Objective To analyse the incidence and outcomes of the different neovascular subtypes in age-related macular degeneration (AMD). Material and methods A retrospective review was carried out on patients with neovascular AMD treated in the University and Polytechnic Hospital la Fe in Valencia by the same retinal physician (RGP) between December 2012 and July 2015. The anatomic classification of the neovascular lesions was recorded, as well as the number of intravitreal treatments administered and the change in visual acuity (VA) obtained throughout the follow-up. Results A total number of 174 eyes of 156 patients (mean age: 79.9 years) with a minimum follow-up of 4 months were included. The anatomic classification of choroidal neovascularisation (CNV) showed the presence of type 1 lesions in 40,8%, type 2 lesions in 12%, type 3 lesions in 31%, and mixed lesions in 14.4%, with 1.7% showing polypoidal choroidal vasculopathy features. Overall, the mean baseline VA was 0,32, improving to 0,38 at 24 months, after having received a mean of 9.3 injections. Type 2, 3, and mixed forms showed a visual result significantly lower than type 1, but there was no significant difference in the polypoidal vasculopathy. Conclusions Type 1 CNV was the most common finding, and was associated with a better visual prognosis, compared to the other neovascular lesions.Sin financiaci贸nNo data JCR 20180.230 SJR (2018) Q3, 91/127 OphthalmologyNo data IDR 2018UE
    corecore